Rosalind Advisors »

Sellas Life Sciences Group I shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Sellas Life Sciences Group I shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Sellas Life Sciences Group I

Tip: Access up to 7 years of quarterly data

All positions including Sellas Life Sciences Group I held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sellas Life Sciences Group I by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.3M 569k 4.05

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Savara (SVRA)
Verastem Com New (VSTM)
X4 Pharmaceuticals Com New (XFOR)
Eyepoint Pharmaceuticals Com New (EYPT)
Cybin Com New (HELP)
Vor Biopharma Com New (VOR)
Vaxcyte (PCVX)
Mediwound Shs New (MDWD)
Celldex Therapeutics Com New (CLDX)
BioCryst Pharmaceuticals (BCRX)
Profound Medical Corp Com New (PROF)
Talphera Com New (TLPH)

View all positions for Rosalind Advisors

Top funds holding Sellas Life Sciences Group I

Group One Trading
Rosalind Advisors
Simplex Trading
Marathon Trading Investment Management
National Bank Of Canada /fi/

View all funds holding Sellas Life Sciences Group I